MoneyWorks4Me

Gland Pharma informs about press release

15 Nov 2023 Evaluate
Gland Pharma has informed that it enclosed attached press release on ‘Gland Pharma receives tentative approval from the United States Food and Drug Administration (US FDA) for Angiotensin II for Injection, 2.5 mg/ ml Single-Dose Vial’

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1869.95
Dr. Reddys Labs. 1205.60
Cipla 1386.95
Lupin 2129.80
Zydus Lifesciences 1166.85
View more..